A high level of innovation translates into a low cost economy.
Thursday 18 August 2016
Cipla: Innovation & Patents
Cipla successfully opposed the grant of a patent to Boehringer for Tiotropium Bromide Monohydrate branded as Spiriva.This is utilized in inhalers.The patent was successfully opposed on the basis that it did not enhance therapeutic efficacy.
No comments:
Post a Comment